Evidence map›Paper›PMID 25091219›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2014

Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation.

Marcelo A Queiroz, Martin Hüllner, Felix Kuhn, Gerhardt Huber, Christian Meerwein, Spyros Kollias, Gustav von Schulthess, Patrick Veit-Haibach

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Role ofCancers · 2024
    Review
  5. The use of PET/MRI in radiotherapy.Insights into imaging · 2024
    Review
  6. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.European journal of nuclear medicine and molecular imaging · 2023
    Article
  7. Article
  8. Article
  9. Are Gadolinium-Enhanced MR Sequences Needed in SimultaneousAJNR. American journal of neuroradiology · 2020
    Article
  10. Article
  11. Comparison ofEuropean journal of nuclear medicine and molecular imaging · 2020
    Article
  12. Clinical utility of simultaneous whole-bodyEuropean journal of nuclear medicine and molecular imaging · 2018
    Article
  13. Article
  14. Review
  15. FDG Whole-Body PET/MRI in Oncology: a Systematic Review.Nuclear medicine and molecular imaging · 2017
    Review
  16. Article
  17. Article
  18. Transmission imaging for integrated PET-MR systems.Physics in medicine and biology · 2016
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marcelo A QueirozDepartment of Medical Radiology, Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland, marcelo.araujoqueiroz@gmail.com.
Martin Hüllner
Felix Kuhn
Gerhardt Huber
Christian Meerwein
Spyros Kollias
Gustav von Schulthess
Patrick Veit-Haibach

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of this study was to analyze whether diffusion-weighted imaging (DWI) adds significant information to positron emission tomography/magnetic resonance imaging (PET/MRI) on lesion detection and characterization in head and neck cancers.

methodsSeventy patients with different head and neck cancers were enrolled in this prospective study. All patients underwent sequential contrast-enhanced (ce) PET/computed tomography (CT) and cePET/MRI using a tri-modality PET/CT-MR setup either for staging or re-staging. First, the DWI alone was evaluated, followed by the PET/MRI with conventional sequences, and in a third step, the PET/MRI with DWI was evaluated. McNemar's test was used to evaluate differences in the accuracy of PET/MRI with and without DWI compared to the standard of reference.

resultsOne hundred eighty-eight (188) lesions were found, and of those, 118 (62.8%) were malignant and 70 (37.2%) were benign. PET/MRI without DWI had a higher accuracy in detecting malignant lesions than DWI alone (86.8% vs. 60.6%, p < 0.001). PET/MRI combined with DWI detected 120 concurrent lesions (89 malignant and 31 benign), PET/MRI alone identified 48 additional lesions (20 malignant and 28 benign), and DWI alone detected 20 different lesions (nine malignant and 11 benign). However, lesions detected on DWI did not change overall staging. SUV maximum and mean were significantly higher in malignant lesions than in benign lesions. DWI parameters between malignant and benign lesions were not statistically different.

conclusionThe use of DWI as part of PET/MRI to evaluate head and neck cancers does not provide remarkable information. Thus, the use of DWI might not be needed in clinical PET/MRI protocols for the staging or restaging of head and neck cancers.

Indexed as

Diffusion Magnetic Resonance ImagingPositron-Emission TomographyAdultAgedAged, 80 and overFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedMultimodal ImagingPredictive Value of TestsTomography, X-Ray Computed

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.